Rockwell Medical Stock News

WIXOM, Mich. , May 23, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron de

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q1 2022 Earnings Conference Call May 16, 2022 4:15 PM ET Company Participants Jason Finkelstein - Investor Relations Russell Ellison - President and Chief Executi

Rockwell Medical Inc (NASDAQ: RMTI) has provided the FDA with the supplemental data requested by the agency in December 2021 for its pending Investigational New Drug (IND) application of Ferric Pyr

WIXOM, Mich. , April 20, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron d

Penny stocks under $1 to watch in April 2022 The post Best Penny Stocks Today? 4 To Buy For Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

WIXOM, Mich., March 09, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI ) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced a poster presentation at the National Home Infusion Association''s (NHIA) 2022 Annual Conference , to be held March 12-16 in Nashville, Tennessee. Details of the poster presentation are as follows: Title: Management of Iron Deficiency Anemia in Home Parenteral Nutrition Patients; Challenges and Opportunities for Improvement Presenting Author: Timothy T. Chole, BSc Econ – SVP, Sales & Marketing, Rockwell Medical Co-Authors: Mark DeLegge, MD - DeLegge Medical Marc Hoffman, MD - Chief Medical Officer, Rockwell Medical Michelle C. Simpson, PharmD, BCSCP - Clinical Program Manager, NHIA Pat Anthony, MS, … Full story available on Benzinga.com

WIXOM, Mich., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment

Rockwell Medical Inc (RMTI) shares closed this week 20.5% higher than it did at the end of last week. The stock is currently up 14.3% year-to-date, down 62.5% over the past 12 months, and down 92.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Shares traded as high as $0.65 and as low as $0.38 this week.Shares closed 76.4% below its 52-week high and 36.8% above its 52-week low.Trading volume this week was 583.0% higher than the 10-day average and 1545.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 9.8% higher than its 5-day moving average, 14.9% higher than its 20-day moving average, and 7.0% lower than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -300.3% The company's stock price performance over the past 12 months lags the peer average by 3514.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Rockwell Medical Inc (RMTI) shares closed today 17.4% higher than it did at the end of yesterday. The stock is currently down 2.7% year-to-date, down 66.2% over the past 12 months, and down 93.6% over the past five years. Today, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.4%. Trading Activity Shares traded as high as $0.65 and as low as $0.38 this week.Shares closed 76.3% below its 52-week high and 37.0% above its 52-week low.Trading volume this week was 46.6% lower than the 10-day average and 80.1% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -45.0% The company's stock price performance over the past 12 months lags the peer average by -8356.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Rockwell Medical Inc''s (NASDAQ: RMTI ) partner, Jeil Pharmaceutical Co Ltd , has received regulatory approval in South Korea for Triferic Injection for iron supplementation therapy and maintaining hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease. Rockwell Medical has an exclusive license agreement with Jeil to commercialize Triferic in South Korea. Regarding the license, Rockwell Full story available on Benzinga.com

Which penny stocks are on your watchlist right now? The post Here Are 3 Penny Stocks You Need to Know About in January appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.

Rockwell Medical (RMTI) soars 17.4% premarket after its partner, Jeil Pharmaceutical Co., Ltd., received regulatory approval for Triferic Injection (ferric pyrophosphate citrate

Rockwell Medical Inc's (NASDAQ: RMTI) partner, Jeil Pharmaceutical Co Ltd, has received regulatory approval in South Korea for Triferic Injection for iron supplementation therapy and maintaining h

The stock price of Rockwell Medical Inc (NASDAQ: RMTI) increased by over 40% during intraday trading today. This is why it happened.